practice guidelines in oncology. Garnering 118 respondents, the guidelines usage survey revealed the physician community's substantial reliance on and regard for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). The NCCN Guidelines are
Search Results
Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem
T he 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Hepatobiliary Cancers (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org ) addresses 4 main tumor groups
Elizabeth Reed, Robin M. Lally, and Roksana Zak
Guidelines in Oncology (NCCN Guidelines) for Breast Cancer direct breast cancer treatment and symptom management, but care of young newly diagnosed women requires providers to combine elements of several guidelines and consider an appropriate order of
Zin W. Myint, Rani Jayswal, Ranjana Arora, Gregory P. Monohan, Amit Goldberg, Roger Fleischman, Roger Herzig, Hayder Saeed, Gerhard C. Hildebrandt, and Reshma Ramlal
, and molecular abnormalities using NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML, version 1.2018. Kaplan-Meier plots and Cox regression analyses were utilized. Results: A total of 105 AML patients were included; baseline
Kristi Maxwell, Eric A. Severson, Meagan Montesion, Ingrid Marino, Rachel Anhorn, and Bethany Sawchyn
,300 AML cases tested with FoundationOne Heme, 62% had an alteration that is included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), and 91% had a clinically relevant alteration identified that could inform diagnosis, prognosis, or
Heather Katz, Hassaan Jafri, Emilia Cindy Leigh, Layana Biglow, Madhulika Urella, and Maria Tria Tirona
Background: Per the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer (available at NCCN.org ), left ventricular ejection fraction (LVEF) should be evaluated prior to and during treatment with trastuzumab. Optimal
Bridgett Harr, Joanna Bodmann, and Helen Tackitt
Guidelines in Oncology (NCCN Guidelines) for Survivorship and develop a comprehensive program. A questionnaire was created to address survivorship-specific concerns. An order set was created to highlight available resources. Additionally, evidence
Ami M. Vyas, Hilary Aroke, and Stephen J. Kogut
). Guideline-concordant initial care within 6 months of cancer diagnosis was defined as per NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). A multivariate logistic regression was performed to identify the significant predictors of guideline
Eric Gratias, David Spangler, and Margaret Rausa
Background: eviCore healthcare uses the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to support its proprietary program for medical oncology drug management. All treatment regimens assigned NCCN Category of Evidence 1, 2A, or 2B
William T. McGivney
transparent, credible, and authoritative NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and NCCN Drugs & Biologics Compendium (NCCN Compendium) begs the question, “why don't all policy decision-makers rely on the evaluative capacity and expert
